CSIMarket Company Name, Ticker, Suppliers, else..
 
Solana Company  (NASDAQ: HSDT)
 
Price: $2.3500 $0.27 12.981%
Day's High: $2.4489998817443848 Week Perf: 0.43 %
Day's Low: $ 2.05 30 Day Perf: 36.63 %
Volume (M): 1,043,063 52 Wk High: $ 25.50
Volume (M$): $ 0 52 Wk Avg: $4.09
Open: $2.13 52 Wk Low: $1.18



 Market Capitalization (Millions $) 180
 Shares Outstanding (Millions) 77
 Employees 21
 Revenues (TTM) (Millions $) 10
 Net Income (TTM) (Millions $) -137
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Helius Medical Technologies Inc. is a medical technology company specializing in the development and commercialization of non-invasive platform technologies used in the treatment of neurological symptoms caused by disease or trauma. Its flagship product, the Portable Neuromodulation Stimulator (PoNS), is a medical device designed to deliver neurostimulation through the tongue to enhance neuroplasticity in the brain. This innovative approach aims to improve symptoms related to neurodegenerative diseases, traumatic brain injuries, and other neurological disorders. The company is headquartered in Newton, Pennsylvania, and operates in both the United States and Canada.


   Company Address: 642 Newtown Yardley Road, Suite 100 Newtown 18940 PA
   Company Phone Number: 944-6100   Stock Exchange / Ticker: NASDAQ HSDT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ECOR   -5.15%    
MDT        3.48% 
NMTC   -16.16%    
VBIO        2176.42% 
ABT   -2.51%    
CELZ   -7.02%    
• View Complete Report
   



Contract

Solana Company Expands Treasury Strategy with Innovative Staking Partnerships

Published Thu, Oct 23 2025 1:21 PM UTC

In a strategic pivot that underscores its commitment to harnessing the power of decentralized finance, Solana Company (NASDAQ: HSDT) has announced its latest moves to enhance its treasury management by partnering with leading blockchain service providers Helius and Twinstake, as well as utilizing Anchorage Digital Bank for secure custody solutions. This groundbreaking approa...
Product Service News

Pioneering Paths Helius Medicals PoNS Device Advances Reimbursement and Clinical Horizons in Neurorehabilitation,

Published Mon, May 12 2025 11:15 AM UTC

Breaking Ground in Neurorehabilitation: Helius Medical s PoNS Device Gains Momentum with New Reimbursements and Clinical Trials Newtown, Pa. April 24, 2024 Helius Medical Technologies, Inc. (Nasdaq:HSDT), a pioneering neurotech company, is making significant strides in advancing neurorehabilitation through its Portable Neuromodulation Stimulator (PoNS) device. Recent dev...
Product Service News

Helius Medical Technologies Paving the Way for Game-Changing Neuromodulation Access

Published Mon, Nov 18 2024 1:01 PM UTC

In today’s ever-evolving healthcare landscape, breakthrough technologies are often met with regulatory hurdles that inhibit their market potential. Helius Medical Technologies, Inc. (NASDAQ: HSDT), a pioneering force in the neuromodulation sector, is making significant strides toward ensuring its innovative Portable Neuromodulation Stimulator (PoNS) gains fair market acces...
Product Service News

Helius Medical Technologies Advances in CMS Reimbursement and Expands PoNS Clinical Trials for Stroke Recover...

Published Mon, Oct 14 2024 9:00 PM UTC

Helius Medical Technologies Announces Key Updates on CMS Reimbursement and Clinical Programs for PoNS Device Helius Medical Technologies, Inc. a neurotech company focused on developing non-implantable and wearable devices for neurological health, has made significant strides in its push to garner broader acceptance and reimbursement for its pioneering Portable Neuromodulatio...
Clinical Study

Breaking Ground in MS Treatment Helius Medical Technologies PoNSTEP Study Reveals Promising Gait Improvement Results...

Published Mon, Sep 30 2024 12:00 PM UTC

Unlocking New Horizons for MS Gait Improvement: Positive Results from Helius Medical Technologies PoNSTEP StudyIn an exciting development for the field of neurological rehabilitation, Helius Medical Technologies, Inc. has announced the preliminary results of its PoNSTEP study, showcasing promising outcomes from the implementation of its innovative PoNS Therapy. According t...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 18.81
Price to Sales (Expected) -
Price to Book 0.91
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.19
Working Capital Ratio 13.9
Leverage Ratio (MRQ) 0.01
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -99.15 $
Revenues (TTM) 0.12 $
Cash Flow (TTM) 0.04 $
Cash 0.06 $
Book Value 2.58 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 456,619
Net Income per Employee (TTM) -6,516,714
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.04

Profitability Ratios Current
Gross Margin (MRQ) 95.03 %
Operating Margin (MRQ) -2751.12 %
Net Margin (MRQ) -2756.12 %
Net Cash Flow Margin (MRQ) -79.73 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Solana's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.